CD274 and musculoskeletal system disorder: The emergence of personalized treatment strategies in cancer therapy, such as immune checkpoint therapy (e.g., PD-1, PD-L1, and CTLA-4 inhibitors) and adoptive T cell therapy (e.g., CAR-T cells), provides inspiration for personalized treatment of musculoskeletal disorders (11, 12).